2012.08.07. Innovimmune featured in Xconomy

Aug 7

Written By Adam Parks

Read the news feature.

Adam Parks https://apollocreativeco.com

2012.10.01. Innovimmune: Structuring Immunotherapies

2012.06.13. Innovimmune awarded NIH NIAID SBIR $0.6 Million grant for the development of its oral NCE INV-88 Macrophage Migration Inhibitory Factor (MIF) inhibitors for Autoimmune Diseases